Si, Y.; Guan, J.; Xu, Y.; Chen, K.; Kim, S.; Zhou, L.; Jaskula-Sztul, R.; Liu, X.M.
Correction: Si et al. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020, 12, 1079. Pharmaceutics 2025, 17, 1317.
https://doi.org/10.3390/pharmaceutics17101317
AMA Style
Si Y, Guan J, Xu Y, Chen K, Kim S, Zhou L, Jaskula-Sztul R, Liu XM.
Correction: Si et al. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020, 12, 1079. Pharmaceutics. 2025; 17(10):1317.
https://doi.org/10.3390/pharmaceutics17101317
Chicago/Turabian Style
Si, Yingnan, JiaShiung Guan, Yuanxin Xu, Kai Chen, Seulhee Kim, Lufang Zhou, Renata Jaskula-Sztul, and X. Margaret Liu.
2025. "Correction: Si et al. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020, 12, 1079" Pharmaceutics 17, no. 10: 1317.
https://doi.org/10.3390/pharmaceutics17101317
APA Style
Si, Y., Guan, J., Xu, Y., Chen, K., Kim, S., Zhou, L., Jaskula-Sztul, R., & Liu, X. M.
(2025). Correction: Si et al. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020, 12, 1079. Pharmaceutics, 17(10), 1317.
https://doi.org/10.3390/pharmaceutics17101317
